Denmark's Smoking Rate and E-cigarette Use Rise with Flavor Ban

Feb.15.2023
Denmark's Smoking Rate and E-cigarette Use Rise with Flavor Ban
Danish smoking and e-cigarette use increased from 2020 to 2022, despite a flavor ban in 2022, according to a report.

According to the latest data released by the Danish National Health Committee in February 2023, smoking and e-cigarette use have both increased in Denmark from 2020 to 2022. It is reported that a flavor ban in Denmark officially took effect on April 1, 2022.


A report has revealed the smoking rate in Denmark from 2020 to 2022.


The percentage of smokers has increased from 18% to 19%.


The percentage of smokers aged 15-29 years has increased from 23% to 25%.


The usage rate of electronic cigarettes has increased from 3% to 5%.


The usage rate of electronic cigarettes among individuals aged 15-29 is between 4% and 7%.


In the years 2020-2022, there was a significant increase in the number of fruit and candy/soft drink flavored electronic cigarettes.


The percentage of users of fruit-flavored electronic cigarettes has increased from 47% to 67%.


The percentage of candy and soft drink flavor users has increased from 21% to 32%.


The percentage of fruit-flavored e-cigarette users aged 15-29 increased from 67% to 83%.


The percentage of candy/soft drink flavor users aged 15-29 has increased from 32% to 41%.


However, the increase in Denmark's smoking rate failed to lead to an increase in the rate of quitting smoking. From 2020 to 2022, the number of e-cigarette users who completely quit smoking decreased from 41% to 38%. This indicates that the ban on electronic cigarettes may decrease their effectiveness as a smoking cessation tool.


Officials from a Danish health research institution have stated that even though Denmark has implemented a flavor ban, illegal e-cigarettes are still circulating through black markets and being sold to children and young people through social media. The Danish authorities do not have enough resources to handle the growing illegal market.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts hosted “Decisive 2026” in Shenzhen, bringing together industry perspectives to examine major shifts in the U.S. new tobacco market in 2025 and their global implications. Sessions covered U.S. market dynamics, technical insights from recently PMTA-authorized products, an investor lens on tobacco capital markets, and 2025 news/product highlights. The event underscored a structural shift from “gray business” toward compliance and sustainable growth, expected to become clearer by 2026.
Jan.09
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
Philip Morris International reported full-year 2025 results on February 6, with smoke-free products accounting for 41.5% of adjusted net revenues, up from 38.7% a year earlier. Total net revenues rose 7.3% to $40.65 billion, while shipment volumes increased 1.4%, widening the gap between revenue and volume growth. Cigarette shipments declined as smoke-free volumes rose 12.8%, driven by heated tobacco, oral nicotine and e-vapor products. Results were released alongside a 9:00 a.m. EST webcast.
Feb.06
After Export Tax Rebates Go to Zero: How China’s E-Cigarette Supply Chain Is Being Reshaped, According to 2Firsts Research
After Export Tax Rebates Go to Zero: How China’s E-Cigarette Supply Chain Is Being Reshaped, According to 2Firsts Research
China’s e-cigarette industry is adjusting to a major policy shift. From April 1, 2026, China will scrap the 13% export VAT rebate on e-cigarette products, a move affecting manufacturers centered in Shenzhen. Industry participants told 2Firsts the change is forcing a reassessment of pricing and capacity, with competition shifting toward cash flow resilience, regulatory compliance, and multi-location strategies.
Industry Insight
Jan.16
Walgreens Brings Vapes Back to Some U.S. Stores; Juul Says It’s in or Near 6,000 Locations
Walgreens Brings Vapes Back to Some U.S. Stores; Juul Says It’s in or Near 6,000 Locations
Walgreens has begun selling vape products again in some U.S. stores, marking a notable reversal after the chain pulled vapes from shelves in 2019 amid concerns over youth use and health risks. Juul says it is expanding across thousands of Walgreens locations, and NJOY also lists Walgreens stores as retailers.
Jan.26 by 2FIRSTS.ai
Mexico City hands over 50,376 vapes and e-cigarettes for destruction, valued at USD 570,000
Mexico City hands over 50,376 vapes and e-cigarettes for destruction, valued at USD 570,000
Mexico City Head of Government Clara Brugada handed over 50,376 vapes and e-cigarettes in the Zócalo for final destruction. The report puts the value at 10 million pesos (about USD 570,000) and says the goods were seized from a stall and a warehouse in the Historic Center, with one person detained because selling these products is illegal.
Jan.19 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11